Cargando…
Decreased expression of connective tissue growth factor in non-small cell lung cancer is associated with clinicopathological variables and can be restored by epigenetic modifiers
PURPOSE: Recent studies indicated undisputed contribution of connective tissue growth factor (CTGF) in the development of many cancers, including non-small cell lung cancer (NSCLC). However, the functional role and regulation of CTGF expression during tumorigenesis remain elusive. Our goal was to de...
Autores principales: | Drzewiecka, Hanna, Gałęcki, Bartłomiej, Jarmołowska-Jurczyszyn, Donata, Kluk, Andrzej, Dyszkiewicz, Wojciech, Jagodziński, Paweł P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4978771/ https://www.ncbi.nlm.nih.gov/pubmed/27393180 http://dx.doi.org/10.1007/s00432-016-2195-3 |
Ejemplares similares
-
Altered expression of 17-β-hydroxysteroid dehydrogenase type 2 and its prognostic significance in non-small cell lung cancer
por: Drzewiecka, Hanna, et al.
Publicado: (2020) -
Klotho expression and nodal involvement as predictive factors for large cell lung carcinoma
por: Brominska, Barbara, et al.
Publicado: (2018) -
High costs as a slow down factor of thoracoscopic lobectomy development in Poland – an institutional experience
por: Piwkowski, Cezary, et al.
Publicado: (2013) -
Completion pneumonectomy and chemoradiotherapy as treatment options in local recurrence of non-small-cell lung cancer
por: Kasprzyk, Mariusz, et al.
Publicado: (2015) -
Physical Activity and DNA Methylation in Humans
por: Światowy, Witold Józef, et al.
Publicado: (2021)